Aquestive Therapeutics (AQST) Inventory: 2017-2025
Historic Inventory for Aquestive Therapeutics (AQST) over the last 8 years, with Sep 2025 value amounting to $7.9 million.
- Aquestive Therapeutics' Inventory rose 12.29% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 12.29%. This contributed to the annual value of $6.0 million for FY2024, which is 10.71% down from last year.
- According to the latest figures from Q3 2025, Aquestive Therapeutics' Inventory is $7.9 million, which was down 2.97% from $8.1 million recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Inventory registered a high of $8.1 million during Q2 2025, and its lowest value of $2.8 million during Q1 2021.
- Its 3-year average for Inventory is $7.1 million, with a median of $7.0 million in 2024.
- In the last 5 years, Aquestive Therapeutics' Inventory dropped by 11.69% in 2021 and then spiked by 134.89% in 2022.
- Aquestive Therapeutics' Inventory (Quarterly) stood at $4.0 million in 2021, then skyrocketed by 43.14% to $5.8 million in 2022, then rose by 17.11% to $6.8 million in 2023, then fell by 10.71% to $6.0 million in 2024, then rose by 12.29% to $7.9 million in 2025.
- Its Inventory was $7.9 million in Q3 2025, compared to $8.1 million in Q2 2025 and $7.2 million in Q1 2025.